[Other] Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study |
|
This post will be closed automatically in 2026-06-25 06:48
Reward10points
|
| |
20
Realization of a chip-based hybrid trapping setup for 87Rb atoms and Yb+ ion crystals
20
Critical Flow Rate: Where Sustainable Gas Production Ends and Well Failure Begins
10
Classifying compounds as prebiotics — scientific perspectives and recommendations
20
The effectiveness of post vividness and interactivity on influencer marketing: do they differ between macro and micro influencers
50
[Full book]Encyclopedia of Drug Policy
